Market Overview

The veterinary drugs market is expected to register a CAGR of 5.8% during the forecast period. Veterinary drugs are used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals, and hormones are developed in order to minimize the attack of harmful viruses and bacterial parasites in animals. According to the American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States. The presence of advanced cost-effective veterinary drugs and rising clinical animal researches are the key driving factors in the veterinary drugs market.

Scope of the Report


As per the scope of the report veterinary drugs are used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals, and hormones are developed in order to minimize the attack of harmful viruses and bacterial parasites in animals. The veterinary drugs market is segmented by Product Type, By Route of Administration and Geography.

Key Market Trends


Parasiticides Segment is Expected to Be the Fastest-Growing Segment

  • Parasites are organisms that survive by attacking pets and farm animals for nourishment and live in or on the body, benefiting from food and protection. Common parasites such as ticks, mosquitos, and fleas live outside the body on the skin or hidden in an animal’s fur which not only harms the animal, they can quickly spread a disease outbreak. For instance, the Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year.
  • According to the American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States.
  • In the year 2017, parasiticides hold a significant market share and are anticipated to show a similar trend over the forecast period.
  • Due to the rise in the prevalence of infectious diseases and an increase in pet ownership are the key driving factors in the parasiticides segment.



North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global veterinary drugs market due to a rise in the prevalence of infectious diseases and the emergence of new technologies in this region. In the year 2017, North America held the highest share and is also expected to continue dominating the market through the forecast period. Moreover, the introduction of new animal-related products and increasing adoption of animals is fueling the growth of the overall regional market to a large extent.

Competitive Landscape


The veterinary drugs market is consolidated competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer AG, Zoetis Animal Healthcare, Virbac S.A, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol S.A, Merck Ltd, Elanco, Intervet Inc, and Bimeda, Inc

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support